State Street Corporation (CDNA) discloses 5.3% beneficial ownership stake in CareDx
Rhea-AI Filing Summary
State Street Corporation has filed a Schedule 13G reporting a passive ownership stake in CareDx, Inc. (CDNA). As of 12/31/2025, State Street reports beneficial ownership of 2,737,752 shares of CareDx common stock, representing 5.3% of the outstanding class.
State Street reports shared voting power over 2,606,232 shares and shared dispositive power over 2,737,752 shares, with no sole voting or dispositive power. The position is held through investment management affiliates, including SSGA Funds Management and various State Street Global Advisors entities, and is certified as being held in the ordinary course of business without the purpose of influencing control.
Positive
- None.
Negative
- None.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What does State Street Corporation report in its Schedule 13G for CareDx (CDNA)?
State Street Corporation reports a passive ownership stake in CareDx common stock. As of 12/31/2025, it beneficially owns 2,737,752 shares, representing 5.3% of the outstanding class, and files on Schedule 13G as an institutional investor holding the position in the ordinary course of business.
Is State Street’s CareDx (CDNA) stake intended to influence control of the company?
State Street certifies that the CareDx shares were acquired and are held in the ordinary course of business. It states they were not acquired and are not held for the purpose of changing or influencing control of CareDx, aligning with the passive intent typical for Schedule 13G filings.
Which State Street affiliates are associated with the CareDx (CDNA) holdings?
The filing identifies several investment management subsidiaries linked to the CareDx position. These include SSGA Funds Management, Inc. and multiple State Street Global Advisors entities in the United States and Europe, which collectively manage the securities reported under State Street Corporation’s beneficial ownership.
Why did State Street file a Schedule 13G instead of a Schedule 13D for CareDx (CDNA)?
A Schedule 13G is used for passive holders that exceed 5% ownership without seeking control. State Street certifies the CareDx shares are held in the ordinary course of business and not to influence control, which fits the criteria for a Schedule 13G rather than a control-oriented Schedule 13D.